Optic Neuritis Treatment Market Size & Share, by Treatment Type (Surgery, Pharmacological); Indication (Optic Neuritis, Neuropathy, Optic Atrophy, Glaucoma, Congenital); End-user (Ambulatory Surgery Centers, Clinics, Hospitals) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 4174
  • Published Date: Jul 27, 2023
  • Report Format: PDF, PPT

Companies Dominating the Optic Neuritis Treatment Landscape

top-features-companies
    • Santen Pharmaceutical Co., Ltd.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Mallinckrodt plc
    • AbbVie Inc.
    • Novartis AG
    • Sanofi-aventis Groupe
    • AdvoCare International
    • Hikma Pharmaceuticals PLC
    • Henry Schein, Inc.
    • Fresenius Kabi USA
    • Pfizer Inc.

     


Browse Key Market Insights with Data Illustration:

In-the-news

In The News

  • Novartis AC to acquire European Commission Approval for Tabrecta, lapatinib, to cure small cell lung cancer. Tabrecta also provides specialized therapy for cured patients living with NSCLC.
  • Hikma Pharmaceuticals PLC to announce to completion of the acquisition of Custopharm Inc. The company is acquired from Water Street Healthcare Partners by getting approval from the US Federal Trade Commission.

Author Credits:  Radhika Gupta, Shivam Bhutani


  • Report ID: 4174
  • Published Date: Jul 27, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Rising incidences of bacterial infections across the globe and the significant increment in global geriatric population are the major factors driving the growth of the market.

The market size of Optic Neuritis Treatment is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2023 – 2035.

The major players in the market are Santen Pharmaceuticals Co., Ltd., Mallinckrodt plc, AbbVie Inc., Novartis AG, Sanofi-aventis Groupe, AdvoCare International, and others.

The hospital sub-segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying